Search the Newsreel

Accelerant Holdings (NYSE: ARX) sharply lifts Q2 2026 profit and revenue

Accelerant Holdings (ARX) agrees to $20.25-per-share Thoma Bravo buyout after strong Q2

Accelerant Holdings (ARX) has entered into a definitive agreement to be acquired by Thoma Bravo in an all-cash merger valued at over $4 billion. Shareholders will receive $20.25 per share, representing a 49% premium to the August 12, 2026 closing price. The deal, supported …

Accelerant, Harmonic surge, Cisco slides premarket on margin outlook

Investing.com - U.S. stock index futures pointed higher on Thursday, as investors digested fresh corporate earnings and deal news while continuing to assess the outlook for inflation and interest rates. By 06:19 ET (10:19 GMT), the Dow futures contract had risen by 112 points, …

ACCELERANT HOLDINGS ($ARX) Releases Q2 2026 Earnings

Accent Resources Says No Undisclosed News Behind Share Price Move

Accelerant to Go Private in $4.4B Deal with Thoma Bravo

Accelerant has agreed to be taken private by private-equity firm Thoma Bravo in a deal valued at over $4 billion. Shareholders will receive $20.25 per share in cash, representing a 49% premium over the company's August 12 closing price. The transaction is anticipated to …

Accent Resources Requests Trading Halt Amid Review of Recent Share Activity

Accent Resources NL Responds to ASX Price Query After Securities Reach Intraday High of $0.64

China Success Finance Names Vice Chairman Xu Kaiying as New Chairman After Zhang Tiewei Resigns

China Success Finance Outlines Board Composition and Committee Roles

WORLD ACCEPTANCE CORP SEC Filing (Aug 12, 2026)

This article reports on a Form 144 SEC filing by World Acceptance Corp (WRLD) on August 12, 2026. The filing indicates a proposed sale of 2000 shares of common stock with an aggregate market value of $381,482.00, acquired through restricted stock vesting on April …

Accenture Stock Trades At A Discount While The Company Buys Its Growth

Dev Accelerator Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

What is Northland Securities' Estimate for ACEL Q3 Earnings?

Accel Entertainment, Inc. (NYSE:ACEL) Receives Consensus Rating of "Moderate Buy" from Analysts

Accent Resources NL (ASX:ACS) Shares Reach 52-Week High as Market Tracks Trading Move

Accent Resources NL (ASX:ACS): Key Developments and Outlook for Its Magnetite Range Project

Dimensional Fund Advisors LP Buys Shares of 2,606,620 Accendra Health, Inc. $ACH

Dimensional Fund Advisors LP recently acquired 2,606,620 shares of Accendra Health, Inc. (NYSE:ACH) during the first quarter, valuing their new stake at approximately $5.94 million. Other institutional investors also modified their holdings, while the company reported missing analyst earnings estimates for the latest quarter. …

World Acceptance director Benjamin Robinson sells $16,853 in shares

Benjamin Robinson III, a director at World Acceptance Corp (NASDAQ:WRLD), sold 90 shares of the company's common stock for $16,853 on August 10, 2026. This transaction leaves him with 4,746 shares directly held. The sale follows a strong 46.6% return for WRLD shares over …

Accendra Health (ACHC) Stock Sinks As Losses Deepen And Cash Stays Tight

Accel Entertainment (ACEL) awards 55,229 performance stock units to its CEO

Accelerate Resources’ Gravity Survey Sharpens Manganese Drill Targets at Woodie Woodie North

World Acceptance director Benjamin Robinson sells $16,853 in shares By Investing.com

Benjamin Robinson, a director at World Acceptance Corp (NASDAQ:WRLD), sold 90 shares of the company's common stock for a total of $16,853. This insider sale follows a strong 46.6% return for WRLD shares over the past six months, despite InvestingPro analysis suggesting the stock …

World Acceptance Corp (WRLD) Director Robinson Benjamin E III Se

World Acceptance (WRLD) director trades 90 shares under 10b5-1 plan

World Acceptance Corp. director Benjamin E. Robinson III sold 90 shares of common stock on August 10, 2026, at $187.26 per share, under a Rule 10b5-1 trading plan. After this transaction, Robinson directly holds 4,746 shares of the company's common stock. The sale totaled …

Will Lower Underwriting Profit Hurt Accelerant Holdings' Q2 Results?

Accelerant Holdings ARX is set to report its second-quarter 2026 results on Aug. 13, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at 16 cents per share on revenues of $274.08 million. The second-quarter earnings estimate …

Accendra Health, Inc. (ACH) Stock Price, News, Quote & History

This article provides comprehensive financial information for Accendra Health, Inc. (ACH), including its stock price, historical data, and recent news. It covers the company's profile as a healthcare solutions provider, its financial performance, earnings trends, and analyst insights. The data indicates significant negative returns …

Research Analysts Offer Predictions for ACEL FY2026 Earnings

Baird Downgrades Accendra Health to Neutral From Outperform, Adjusts PT to $1.50 From $6

Baird has downgraded Accendra Health (ACH) from an "Outperform" rating to "Neutral" and significantly lowered its price target from $6 to $1.50. This change in rating and price target follows other recent analyst adjustments, indicating a more cautious outlook for the company. Accendra Health …

Press Release: Accendra Health Reports Second Quarter 2026 Financial Results

This press release from Accendra Health reports their financial results for the second quarter of 2026. Further details on their performance would be contained within the full report.

Accent Resources (ASX: ACS) Shares up Over 600% - Here’s What Happening

Baird downgrades Accendra Health stock rating on weak results

Baird downgraded Accendra Health Inc. (NYSE:ACH) from Outperform to Neutral and cut its price target due to weak results and internal issues. The firm cited unreliable guidance, impending competitive bidding, and the company's micro-cap status with an active at-the-market offering program and poison pill. …

Accendra Health Ord Shs (ACH) Earnings Forecast: Future EPS & Revenue Growth Estimates

Accent Resources Cites Testwork Results in ASX Price Query Response

Credit Acceptance’s Q2 Earnings Call: Our Top 5 Analyst Questions

Credit Acceptance's Q2 Earnings Call: Our Top 5 Analyst Questions Credit Acceptance's second quarter results reflected a mix of margin expansion and modest loan volume improvements, even as revenue growth remained limited. Management highlighted that profitability gains stemmed from deliberate operational changes, including tighter …

ACCENDRA HEALTH INC : BAIRD CUTS TO NEUTRAL RATING; CUTS TARGET PRICE TO $1.5 FROM $6

Baird has downgraded Accendra Health Inc. to a Neutral rating from its previous Outperform rating. Concurrently, the investment firm significantly reduced its target price for Accendra Health Inc. shares to $1.50 from the prior $6.00. This adjustment indicates a revised outlook on the company's …